When we test new medicines, we are often looking for ways to fight advanced diseases like breast cancer. However, sometimes these treatments can trigger unexpected and dangerous reactions in the body.
In a recent case report, a patient with advanced breast cancer received a drug called pucotenlimab. Following the treatment, the patient developed severe neurological symptoms. This reaction was linked to neuromyelitis optica spectrum disorder, which is a rare condition that attacks the central nervous system.
The situation became even more critical as the patient developed multiple organ dysfunction syndrome, a state where several organs fail at once. Sadly, the patient passed away after these severe adverse reactions.
Because this report focuses on just one person, we cannot say for certain if this will happen to others. However, it highlights how difficult it is for doctors to manage high-grade immune-related side effects, which can be life-threatening and hard to diagnose.